Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Redfield

Showing results (91-100 of 192) with videos related to

Pageof 20
Sort By:
Clinical Nephrology|November 1, 2019
Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction
Jillian L Descourouez, Margaret R Jorgenson, Sandesh Parajuli, et al.
AIDS (London, England)|June 5, 2007
CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1Alonso Heredia, Bruce Gilliam, Anthony DeVico, et al.
Plos One|October 13, 2022
APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant modelNatalie M Bath, Bret M Verhoven, Nancy A Wilson, et al.
Pharmacotherapy|May 26, 2018
Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant RecipientsMagdalena Siodlak, Margaret R Jorgenson, Jillian L Descourouez, et al.
AIDS (London, England)|July 18, 2009
Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cellsDavid J Riedel, Mohammad M Sajadi, Cheryl L Armstrong, et al.
AIDS Research and Human Retroviruses|January 10, 2014
Indirubin 3'-monoxime, from a Chinese traditional herbal formula, suppresses viremia in humanized mice infected with multidrug-resistant HIVAlonso Heredia, Senthilkumar Natesan, Nhut M Le, et al.
Plos One|October 25, 2019
Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant modelNatalie M Bath, Xiang Ding, Bret M Verhoven, et al.
The Annals of Pharmacotherapy|August 29, 2017
High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 4, 2015
Predictors and outcomes of delayed graft function after living-donor kidney transplantationRobert R Redfield, Joseph R Scalea, Tiffany J Zens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Treatment outcomes of recommended first-line antiretroviral regimens in resource-limited clinicsAnthony Amoroso, Martine Etienne-Mesubi, Anthony Edozien, et al.
Pageof 20

Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
Clinical Nephrology|November 1, 2019
Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction
Jillian L Descourouez, Margaret R Jorgenson, Sandesh Parajuli, et al.
AIDS (London, England)|June 5, 2007
CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1Alonso Heredia, Bruce Gilliam, Anthony DeVico, et al.
Plos One|October 13, 2022
APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant modelNatalie M Bath, Bret M Verhoven, Nancy A Wilson, et al.
Pharmacotherapy|May 26, 2018
Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant RecipientsMagdalena Siodlak, Margaret R Jorgenson, Jillian L Descourouez, et al.
AIDS (London, England)|July 18, 2009
Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cellsDavid J Riedel, Mohammad M Sajadi, Cheryl L Armstrong, et al.
AIDS Research and Human Retroviruses|January 10, 2014
Indirubin 3'-monoxime, from a Chinese traditional herbal formula, suppresses viremia in humanized mice infected with multidrug-resistant HIVAlonso Heredia, Senthilkumar Natesan, Nhut M Le, et al.
Plos One|October 25, 2019
Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant modelNatalie M Bath, Xiang Ding, Bret M Verhoven, et al.
The Annals of Pharmacotherapy|August 29, 2017
High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 4, 2015
Predictors and outcomes of delayed graft function after living-donor kidney transplantationRobert R Redfield, Joseph R Scalea, Tiffany J Zens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Treatment outcomes of recommended first-line antiretroviral regimens in resource-limited clinicsAnthony Amoroso, Martine Etienne-Mesubi, Anthony Edozien, et al.
Pageof 20